Audited Results of Nath Bio-Genes (India) Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	362.31	332.62	301.29	278.36	307.56
Manufacturing Expenses	178.72	101.09	71.88	94.60	124.10
Personnel Expenses	30.31	27.98	23.23	24.78	23.69
Selling Expenses	4.75	5.05	3.70	1.63	1.94
Administrative Expenses	164.16	145.46	119.97	99.52	89.19
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	310.01	282.24	252.40	241.13	240.84
Operating Profit	52.29	50.38	48.89	37.24	66.72
Other Recurring Income	4.73	0.65	0.56	1.85	1.67
Adjusted PBDIT	57.02	51.04	49.45	39.09	68.39
Financial Expenses	9.65	9.10	10.12	10.61	8.82
Depreciation	3.79	3.26	3.01	3.08	2.82
Other Write offs	0	0	0	0	0
Adjusted PBT	43.58	38.67	36.32	25.40	56.75
Tax Charges	1.98	1.95	1.15	3.95	1.09
Adjusted PAT	41.60	36.73	35.17	21.44	55.66
Non Recurring Items	0.54	3.45	0	-88.78	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	42.14	40.18	35.17	-67.34	55.66
Equity Dividend	3.80	3.80	3.80	3.80	0
Preference Dividend	0	0	0	0	0
Retained Earnings	480.55	442.21	405.84	374.47	445.61

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article